Evidence map›Paper›PMID 39080249›Full record

ArticleNature communications2024

Machine learning-guided co-optimization of fitness and diversity facilitates combinatorial library design in enzyme engineering.

Kerr Ding, Michael Chin, Yunlong Zhao, Wei Huang, Binh Khanh Mai, Huanan Wang, Peng Liu, Yang Yang, Yunan Luo

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Efficient, Few-shot Directed Evolution with Energy Rank Alignment.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  9. Review
  10. Article
  11. Best Practices for Machine Learning-Assisted Protein Engineering.Journal of chemical information and modeling · 2025
    Review
  12. Article
  13. Building a Synthetic Cell Together.Nature communications · 2025
    Review
  14. Article
  15. Article
  16. Engineering CAR-T Therapeutics for Enhanced Solid Tumor Targeting.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kerr Ding *School of Computational Science and Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA.ORCID 0000-0003-1124-6404
Michael Chin *Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID 0000-0002-8943-7262
Yunlong Zhao *Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.ORCID 0009-0009-0330-6885
Wei HuangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.
Binh Khanh MaiDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, 15260, USA.ORCID 0000-0001-8487-1417
Huanan WangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA.
Peng LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, 15260, USA. pengliu@pitt.edu.ORCID 0000-0002-8188-632X
Yang YangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, 93106, USA. yang@chem.ucsb.edu.ORCID 0000-0002-4956-2034
Yunan LuoSchool of Computational Science and Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA. yunan@gatech.edu.ORCID 0000-0001-7728-6412

Funding

Computational Models for Reactivity and Selectivity in Transition Metal-Catalyzed Olefin FunctionalizationR35GM128779 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Peng Liu · 2018 to 2026
$2.9M
An Evolvable Metalloenzyme Platform for Stereoselective Radical BiocatalysisR35GM147387 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Yang Yang · 2022 to 2026
$2.0M
Integrative deep learning algorithms for understanding protein sequence-structure-function relationships: representation, prediction, and discoveryR35GM150890 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI Yunan Luo · 2023 to 2026
$1.6M
National Science Foundation (NSF) DMR-1933487NIGMS NIH HHS R35 GM128779NIGMS NIH HHS R35 GM147387NIGMS NIH HHS R35 GM150890U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM128779U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM147387U.S. Department of Health & Human Services | National Institutes of Health (NIH) (R35GM150890
6 · The paper itself

Abstract

The effective design of combinatorial libraries to balance fitness and diversity facilitates the engineering of useful enzyme functions, particularly those that are poorly characterized or unknown in biology. We introduce MODIFY, a machine learning (ML) algorithm that learns from natural protein sequences to infer evolutionarily plausible mutations and predict enzyme fitness. MODIFY co-optimizes predicted fitness and sequence diversity of starting libraries, prioritizing high-fitness variants while ensuring broad sequence coverage. In silico evaluation shows that MODIFY outperforms state-of-the-art unsupervised methods in zero-shot fitness prediction and enables ML-guided directed evolution with enhanced efficiency. Using MODIFY, we engineer generalist biocatalysts derived from a thermostable cytochrome c to achieve enantioselective C-B and C-Si bond formation via a new-to-nature carbene transfer mechanism, leading to biocatalysts six mutations away from previously developed enzymes while exhibiting superior or comparable activities. These results demonstrate MODIFY's potential in solving challenging enzyme engineering problems beyond the reach of classic directed evolution.

Indexed as

Directed Molecular EvolutionMachine LearningMutationProtein EngineeringAlgorithmsBiocatalysisEnzymesGene LibraryEnzymes

Identifiers

PMID39080249
PMCPMC11289365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.